We have located links that may give you full text access.
Removal of toluene using ozone at room temperature over mesoporous Mn/Al 2 O 3 catalysts.
Environmental Research 2019 March 8
The catalytic oxidation of toluene with ozone at room temperature was carried out over hierarchically ordered mesoporous catalysts (CeO2 (meso), Mn2 O3 (meso), ZrO2 (meso), and γ-Al2 O3 (meso)) and Al2 O3 with various textural properties and phases (γ-Al2 O3 (meso), γ-Al2 O3 (13 nm), and α-Al2 O3 ) to examine the effects of the nature of the catalyst on the catalytic activity. The catalysts were characterized by N2 -physisorption measurements, powder X-ray diffraction, temperature programmed reduction, X-ray photoelectron spectroscopy and scanning transmission electron microscopy with energy dispersive spectroscopy. Among the ordered mesoporous catalysts, γ-Al2 O3 (meso) had the highest toluene removal efficiency because of its highest surface area and pore volume, which in turn was selected for further investigation. Manganese (Mn) was introduced to various Al2 O3 to improve the toluene removal efficiency. Comparing the Mn-loaded catalysts supported on various Al2 O3 with different crystalline phases or pore structures, Mn/γ-Al2 O3 (meso), had the highest catalytic activity as well as the highest CO2 /CO ratio. The higher activity was attributed to the larger surface area, weaker interaction between Mn and Al2 O3 , and larger portion of Mn2 O3 phase. The increase in ozone concentration led to an improvement in the carbon balance but this enhancement was insufficient due to the deposition of by-products on the catalyst. After long term tests at room temperature, the reaction intermediates and carbonaceous deposits of the used catalysts were identified.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app